Analysis abstract


Nature Genetics 40, 499 - 507 (2008)
Published online: 28 April 2008 | doi:10.1038/ng.127

An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

Ittai Ben-Porath1,2,5, Matthew W Thomson3, Vincent J Carey4, Ruping Ge1, George W Bell1, Aviv Regev3 & Robert A Weinberg1,2


Cancer cells possess traits reminiscent of those ascribed to normal stem cells. It is unclear, however, whether these phenotypic similarities reflect the activity of common molecular pathways. Here, we analyze the enrichment patterns of gene sets associated with embryonic stem (ES) cell identity in the expression profiles of various human tumor types. We find that histologically poorly differentiated tumors show preferential overexpression of genes normally enriched in ES cells, combined with preferential repression of Polycomb-regulated genes. Moreover, activation targets of Nanog, Oct4, Sox2 and c-Myc are more frequently overexpressed in poorly differentiated tumors than in well-differentiated tumors. In breast cancers, this ES-like signature is associated with high-grade estrogen receptor (ER)-negative tumors, often of the basal-like subtype, and with poor clinical outcome. The ES signature is also present in poorly differentiated glioblastomas and bladder carcinomas. We identify a subset of ES cell-associated transcription regulators that are highly expressed in poorly differentiated tumors. Our results reveal a previously unknown link between genes associated with ES cell identity and the histopathological traits of tumors and support the possibility that these genes contribute to stem cell–like phenotypes shown by many tumors.

Top
  1. Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
  2. Department of Biology and Ludwig Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
  3. Department of Biology, Massachusetts Institute of Technology, and Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
  4. Channing Laboratory and Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
  5. Present address: Hadassah School of Medicine, The Hebrew University of Jerusalem, Ein-Kerem, Jerusalem 91120, Israel.

Correspondence to: Robert A Weinberg1,2 e-mail: weinberg@wi.mit.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

REVIEWS

Mining gene expression profiles: expression signatures as cancer phenotypes

Nature Reviews Genetics Review (01 Aug 2007)

NEWS AND VIEWS

Mammary development meets cancer genomics

Nature Medicine News and Views (01 Aug 2009)